| Literature DB >> 33704815 |
Bardia Nourbakhsh1, Christian Cordano2, Carlo Asteggiano2,3, Klemens Ruprecht4, Carolin Otto4, Alice Rutatangwa2, Allysa Lui2, Janace Hart2, Eoin P Flanagan5, Judith A James6, Emmanuelle Waubant2.
Abstract
Although Epstein-Barr virus (EBV) is hypothesized to be a prerequisite for multiple sclerosis (MS), up to 15% of children with a diagnosis of MS were reported to be EBV-seronegative. When re-evaluating 25 EBV-seronegative children out of 189 pediatric patients with a diagnosis of clinically isolated syndrome/MS, we found anti-myelin oligodendrocyte glycoprotein (MOG) antibody in 11 of 25 (44%) EBV-seronegative but only 9 of 164 (5.5%, p < 0.001) EBV-seropositive patients. After critical review, MS remained a plausible diagnosis in only 4 of 14 EBV-seronegative/MOG antibody-negative patients. In children with an MS-like presentation, EBV seronegativity should alert clinicians to consider diagnoses other than MS, especially MOG-antibody disease. ANN NEUROL 2021;89:1234-1239.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33704815 PMCID: PMC8244760 DOI: 10.1002/ana.26062
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 11.274